A large share of the interest in stem cell therapy traces back to a handful of podcast episodes. It is worth separating what was actually said from what has been built on top of it.
What Joe Rogan Has Actually Said
Rogan has described on his podcast travelling to Panama for stem cell treatment for long-standing shoulder and joint problems, at a clinic using umbilical cord derived mesenchymal stem cells administered intravenously and into the affected joints. He has spoken about the experience positively on several occasions and credited it with a marked improvement in shoulder pain and range of movement.
That is the substance of the public record: a personal account of a treatment, given by the person who received it. Everything beyond that — the inference that the same protocol will produce the same result in a different body — is added by the listener, not by him.
Why Panama, and What That Tells You
The reason patients from the United States travel for this kind of treatment is regulatory rather than clinical. In the US, most mesenchymal cell protocols for orthopaedic and systemic conditions are restricted to clinical trials. Several jurisdictions — Panama, Mexico, Thailand, Japan and South Korea among them — operate frameworks that permit supervised treatment outside a trial setting.
Availability abroad is a difference in permission structures, not proof that the evidence is stronger abroad. We look at that comparison in more detail in which country has the best stem cell therapy.
Why One Account Is Not Evidence
A single testimonial, however credible the person giving it, is missing everything that makes a result interpretable. There is no control group, so there is no way to know what would have happened without treatment. There is no independent imaging follow-up published for inspection. There is no separation of the treatment effect from concurrent rest, physiotherapy, modified training and the natural fluctuation of musculoskeletal pain, which improves and worsens in cycles.
There is also selection bias in what reaches an audience. People who improve talk about it; people who did not usually say nothing. That asymmetry is not dishonesty — it is simply how anecdote works, and it is why medicine relies on trials instead.
What the Evidence Does Support
For joint and soft tissue problems, mesenchymal stem cell therapy sits in the investigational tier. Published trials in knee osteoarthritis and some tendon and shoulder conditions report improvements in pain scores and function in a proportion of patients, with studies generally small, heterogeneous in protocol, and inconsistent in how outcomes are measured.
The realistic aim is symptom and function improvement in suitable candidates, not regrowth of a joint. Where structural damage is advanced, the honest answer is often that surgical options remain the appropriate route. Our joint pain treatment page describes what assessment looks for, and what stem cells can fix or cure in 2026 sets out the wider picture.
If a Podcast Prompted Your Search
That is a perfectly reasonable starting point — but treat it as the beginning of the enquiry rather than its conclusion. The useful next step is to find out whether your own diagnosis and imaging make you a plausible candidate, and what a physician expects treatment to change in your particular case.
Before committing, it is worth reading our checklist for choosing a stem cell clinic and our review of side effects and what to expect afterwards.
Find Out Whether You Are a Candidate
Send your diagnosis and recent imaging and our medical team will tell you whether treatment is appropriate before discussing anything else. Learn more about MRC Healthcare or arrange a consultation.
Schedule a Consultation
